Conclusion: Integration and synthesis

Borderline Personality and Mood Disorders: Comorbidity and Controversy

Volumn , Issue , 2015, Pages 255-270

  Choi Kain, Lois W ^a,b   Gunderson, John G ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84944053330     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-1314-5_14     Document Type: Chapter

References (45)

1. Stone MH. Assessing vulnerability to schizophrenia or manic-depression in borderline states. Schizophr Bull. 1979;5(1):105–10.
2. Akiskal H, Chen SE, Davis GC, Puzantian VR, Kashgarian MM, Bolinger JM. Borderline: an adjective in search of a noun. J Clin Psychiatry. 1985;46(2):41–8.
3. Gunderson JG, Elliott GR. The interface between borderline personality disorder and affective disorder. Am J Psychiatry. 1985;142(3):277–88.
4. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatry. 1998;155:1733–9.
5. McGlashan TH, Grilo CM, Skodol AE, Gunderson JG, Shea MT, Morey LC, et al. The Collaborative Longitudinal Personality Disorders Study: baseline Axis I/II and II/II diagnostic co-occurence. Acta Psychiatr Scand. 2000;102(4):256–64.
6. Sass H, Junemann K. Affective disorders, personality and personality disorders. Acta Psychiatr Scand Suppl. 2013;108(S418):34–40.
7. Links PS, Steiner M, Huxley G. The occurrence of borderline personality disorder in the families of borderline patients. J Pers Disord. 1988;2:14–20.
8. Zanarini MC, Gunderson JG, Marino MF, Schwartz EO, Frankenburg FR. DSM-III disorders in the families of borderline outpatients. J Pers Disord. 1988;2:292–302.
9. Silverman JM, Pinkham L, Horvath TB, Coccaro EF, Klar H, Schear S, et al. Affective and impulsive personality disorder traits in the relatives of patients with borderline personality disorder. Am J Psychiatry. 1991;148:1378–85.
10. Krueger RF, Caspi A, Moffitt TE, Silva PA. The structure and stability of common mental disorders (DSM-II-R): a longitudinal-epidemiological study. J Abnorm Psychol. 1988;107:216–27.
11. Kessler RC, Ormel J, Petukhova M, McLaughlin KA, Green JG, Russo LJ, et al. Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch Gen Psychiatry. 2011;68(1):90–100.
12. Kotov R, Ruggero CJ, Krueger RF, Watson D, Yuan Q, Zimmerman M. New dimensions in the quantitative classification of mental illness. Arch Gen Psychiatry. 2011;68(10):1003–11.
13. Roysamb E, Kendler KS, Tambs K, Orstavik RE, Neale MC, Aggen SH, et al. The joint structure of DSM-IV Axis I and Axis II disorders. J Abnorm Psychol. 2011;120(1):198–209.
14. Hudson JI, Javaras KN, Laird NM, VanderWeele TJ, Pope HG, Hernan MA. A structural approach to the familial coaggregation of disorders. Epidemiology. 2008;19(3):431–9.
15. Gunderson JG, Phillips KA. A current view of the interface between borderline personality disorder and depression. Am J Psychiatry. 1991;148:967–75.
16. Koenigsberg HW, Anwunah I, New AS, Mitropoulou V, Schopick F, Siever LJ. Relationship between depression and borderline personality disorder. Depress Anxiety. 1999;10(4):158–67.
17. Akiskal HS, McKinney Jr WT. Depressive disorders: toward a unified hypothesis. Science. 1973;182(4107):20–9.
18. Blatt SJ, Zuroff DC. Interpersonal relatedness and self-definition: two prototypes for depression. Clin Psychol Rev. 1992;12(5):527–62.
19. Gunderson JG, Lyons-Ruth K. BPD’s interpersonal hypersensitivity phenotype: a geneenvironment- developmental model. J Pers Disord. 2008;22.
20. Choi-Kain LW, Fitzmaurice GM, Zanarini MC, Laverdiere O, Gunderson JG. The relationships between self-reported attachment styles, interpersonal dysfunction, and borderline personality disorder. J Nerv Ment Dis. 2009;197(11):816–21.
21. Staebler K, Helbing E, Rosenbach C, Renneberg B. Rejection sensitivity and borderline personality disorder. Clin Psychol Psychother. 2011;18(4):275–83.
22. Zanarini MC, Frankenburg FR. Emotional hypochondriasis, hyperbole, and the borderline patient. J Psychother Pract Res. 1994;3:25–36.
23. Zanarini MC, Frankenburg FR, Reich DB, Silk KR, Hudson JI, McSweeney LB. The subsyndromal phenomenology of borderline personality disorder a 10-year follow-up study. Am J Psychiatry. 2007;164(6):929–35.
24. Linehan MM. Cognitive behavioral treatment of borderline personality disorder. New York: Guilford Press; 1993.
25. Bateman A, Fonagy P. Psychotherapy for borderline personality disorder: mentalization based treatment. Oxford: Oxford University Press; 2004.
26. Parker G, Manicavasgar V. Modelling and managing the depressive disorders: a clinical guide. New York: Cambridge University Press; 2005.
27. Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush AJ. What Did STAR*D Teach Us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv. 2009;60(11):1439–45.
28. Gunderson JG, Morey LC, Stout RL, Skodol AE, Shea MT, McGlashan TH, et al. Major depressive disorder and borderline personality disorder revisited: longitudinal interactions. J Clin Psychiatry. 2004;65:1049–56.
29. Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush AJ, Schatzberg AF, et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronis forms of major depression and childhood trauma. Proc Natl Acad Sci U S A. 2003;100(24):14293–6.
30. Davidson K, Norrie J, Tyrer P, Gumley A, Tata P, Murray H, et al. The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. J Pers Disord. 2006;20(5):450–65.
31. McMain SF, Links PS, Gnam WH, Guimond T, Cardish RJ, Korman L, et al. A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. Am J Psychiatry. 2009;166(12):1365–74.
32. Clarkin JF, Levy KN, Lenzenweger MF, Kernberg OF. Evaluating three treatments for borderline personality disorder: a multiwave study. Am J Psychiatry. 2007;164(6):922–8.
33. Gunderson JG, Weinberg I, Choi-Kain L. Borderline personality disorder. Focus. 2013;11: 129–45.
34. Wnuk S, McMain S, Links PS, Habinski L, Murray J, Guimond T. Factors related to dropout from treatment in two outpatient treatments for borderline personality disorder. J Pers Disord. 2013;27(6):716–26.
35. Lauder SD, Berk M, Castle DJ, Dodd S, Berk L. The role of psychotherapy in bipolar disorder. Med J Aust. 2010;193(4 Suppl):S31–S35.
36. Mojtabai R, Olfson M. National trends in long-term use of antidepressant medications: results from the US National Health and Nutrition Examination Survey. J Clin Psychiatry. 2014;75: 169–77.
37. Fava GA, Offidani E. The mechanisms in antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(7):1593–602.
38. Mathew SJ, Charney DS. Publication bias and the efficacy of antidepressants. Am J Psychiatry. 2009;166(2):140–5.
39. Khan A, Bhat A, Kolts R, Thase ME, Brown W. Why has the antidepressant-placebo difference in antidepressant clinical trials diminished over the past three decades? CNS Neurosci Ther. 2010;16(4):217–26.
40. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial Severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5(2):e45.
41. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303:47–53.
42. Pagura J, Katz LY, Mojtabai R, Druss BG, Cox B, Sareen J. Antidepressant use in the absence of common mental disorders in the general population. J Clin Psychiatry. 2011;72(4): 494–501.
43. Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in officebased psychiatry. Arch Gen Psychiatry. 2010;67(1):26–36.
44. Mojtabai R, Olfson M. National trends in psychotherapy by office-based psychiatrists. Arch Gen Psychiatry. 2008;65(8):962–70.
45. McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry. 2013;74(6):595–602.